Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches - Archive ouverte HAL Access content directly
Journal Articles Journal of Antimicrobial Chemotherapy Year : 2022

Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches

Domains

Life Sciences [q-bio] Microbiology and Parasitology Virology Life Sciences [q-bio] Microbiology and Parasitology Protistology Life Sciences [q-bio] Microbiology and Parasitology Mycology Life Sciences [q-bio] Microbiology and Parasitology Bacteriology

Sandy Mzembaba  : Connect in order to contact the contributor

https://hal-normandie-univ.archives-ouvertes.fr/hal-03706317

Submitted on : Monday, June 27, 2022-3:47:22 PM

Last modification on : Friday, August 5, 2022-9:28:15 AM

Not file

Dates and versions

hal-03706317 , version 1 (27-06-2022)

Identifiers

Cite

Charlène Martin, Guillemette Unal, Jean-Christophe Plantier, Elodie Alessandri-Gradt. Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches. Journal of Antimicrobial Chemotherapy, 2022, ⟨10.1093/jac/dkac143⟩. ⟨hal-03706317⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

COMUE-NORMANDIE UNIROUEN UNICAEN DYNAMICURE
17 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More